Cannabix Technologies Inc. BLOZF

Company Overview

Cannabix Technologies Inc. is a Canadian technology company focused on the development of non-invasive breath testing devices intended to detect delta-9 tetrahydrocannabinol (THC) and alcohol impairment. The company operates primarily in the cannabis detection, public safety technology, and analytical instrumentation industries. Its core objective is to commercialize portable breathalyzer systems for law enforcement, workplace safety, and other regulated environments where impairment screening is required.

The company’s principal business lines center on the development of the Cannabix Marijuana Breathalyzer platform and related alcohol screening technologies. Public disclosures and investor materials indicate that Cannabix has concentrated on intellectual property development, prototype testing, and validation studies rather than large-scale commercial revenue generation. The company evolved from an early-stage technology issuer into a specialized developer of breath-based impairment detection systems as cannabis legalization expanded across North America and other jurisdictions. Its positioning is tied to the potential demand for rapid roadside and workplace impairment screening tools that do not require blood, urine, or saliva collection.

Business Operations

Cannabix conducts research, engineering, and product development activities focused on portable breath analysis systems. Its operations are centered around the development of THC Breath Analyzer technologies and related sensor platforms intended to identify recent cannabis use from exhaled breath. The company has also disclosed work involving alcohol breath testing systems and collaborations with scientific and engineering partners to improve detection accuracy, sample collection, and device portability.

The company’s operations are primarily based in Canada, with technology development and commercialization efforts directed toward both domestic and international public safety markets. Cannabix has reported relationships with laboratory partners, patent counsel, and engineering contractors supporting product development. Public filings indicate the company controls a portfolio of patents and patent applications related to breath capture systems, chemical detection methodologies, and related analytical technologies. Data regarding large-scale commercial deployments or material recurring revenue remains limited based on available public sources.

Strategic Position & Investments

Cannabix’s strategic direction has focused on advancing breath-based impairment detection technologies toward regulatory validation and potential commercial adoption. Growth initiatives have included prototype refinement, patent expansion, scientific testing, and the pursuit of partnerships with law enforcement agencies and research institutions. The company has consistently emphasized the need for scientifically defensible cannabis impairment testing solutions as legalization frameworks evolve.

The company’s investments have primarily been directed toward intellectual property, engineering development, and clinical or laboratory validation activities rather than acquisitions of operating businesses. Cannabix has highlighted involvement in emerging sectors connected to public safety technology, roadside impairment enforcement, and cannabis regulation. Public disclosures reference ongoing efforts to improve device sensitivity, portability, and real-time analytical capability. Information regarding material subsidiaries, large portfolio holdings, or transformative acquisitions is limited in publicly available filings.

Geographic Footprint

Cannabix Technologies Inc. is headquartered in Canada, with operations and corporate activities primarily associated with the Canadian market. The company’s securities have traded on the Canadian Securities Exchange and in U.S. over-the-counter markets under the ticker BLOZF. Its technology development activities are intended to address demand in multiple jurisdictions where cannabis legalization or impairment enforcement frameworks are developing.

The company has referenced potential market applicability across North America, including Canada and the United States, particularly in roadside law enforcement and workplace safety settings. Cannabix’s intellectual property strategy and commercialization discussions indicate interest in broader international applicability, although publicly verified information regarding significant operating facilities or direct commercial operations outside Canada remains limited.

Leadership & Governance

Cannabix Technologies has historically been led by executives with backgrounds in public markets, technology development, and corporate finance. The company’s governance structure follows the framework typical of publicly listed Canadian technology issuers, with oversight provided by executive management and a board of directors. Strategic messaging from leadership has emphasized scientific validation, regulatory credibility, and long-term commercialization of non-invasive impairment detection technologies.

Key executives identified in public company disclosures include:

• Rav Mlait – Chief Executive Officer
• Kal Malhi – Director
• Dev Randhawa – Director
• Riaz Bandali – Corporate Secretary

Data regarding broader executive turnover, expanded senior management structure, or detailed leadership philosophy is inconclusive based on available public sources.